Responses
Clinical/translational cancer immunotherapy
Original research
Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort
Compose a Response to This Article
Other responses
No responses have been published for this article.